In late April, the California Court of Appeals delivered a blow to plaintiffs who file lawsuits against medical device manufacturers based on an alleged “failure to train” physicians on how to use prescription medical devices. The decision in Glennen v. Allergan is significant because the field of available product liability claims against Class III manufacturers has narrowed considerably since 2008, when the United States Supreme Court held that lawsuits challenging the safety and efficacy of devices approved by FDA are federally preempted.
Researchers at Harvard University and Boston Children’s Hospital have unveiled a powered soft robotic system that wraps around the heart to help augment the cardiac output. Reminiscent of a heart massage, the device makes intimate […]
Orthopedics This Week – One of Wall Street’s top research groups has concluded that the May 4 passage of the AHCA, if ultimately signed into law by President Trump, would likely reduce orthopedic procedure volumes 0.7% in 2018 and, cumulatively, cut overall volumes 1.2% in 2026. […]
For years, medtech manufacturers tweaked their current products, added a few, bells and whistles, and slapped on a price premium and called it innovation. With the move to value-based care, those days are well behind […]